Ghrelin as a potential anti-obesity target.
T. Horvath,T. Castaňeda,2 Authors,M. Tschöp
2003 · DOI: 10.2174/1381612033454748
Current pharmaceutical design · 72 Citations
TLDR
Based on growing experience with compounds targeting the neuroendocrine regulation of energy balance, it is quite possible that a ghrelin antagonist will either fail to cure obesity due to the existence of compensatory mechanisms or undesired effects might reveal the true biological function of gh Relin.
Cited Papers
Citing Papers
